Quarterly Financial Data (Tables)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information [Table Text Block]

(In millions, except per share amounts)				Three Months Ended
	March 31		June 30			Sept. 30		Dec. 31
Consolidated Results
2014
Total revenues	$	8,496	$	8,733		$	8,757	$	8,928
Income before income taxes		853		901			818		732
Shareholders' net income		528		573			534		467
Shareholders' net income per share:	1
Basic		1.96		2.16			2.04		1.80
Diluted		1.92		2.12			2.01		1.77
2013
Total revenues	$	8,183	$	7,980		$	8,066	$	8,151
Income before income taxes		74		767			799		536
Shareholders' net income		57	(1)	505	(2)		553		361	(3)
Shareholders' net income per share:	1
Basic		0.20		1.79			1.99		1.32
Diluted		0.20		1.76			1.95		1.29
Stock and Dividend Data
2014
Price range of common stock — high	$	90.63	$	93.20		$	97.28	$	105.73
— low	$	75.37	$	73.47		$	87.33	$	85.75
Dividends declared per common share	$	0.04	$	-		$	-	$	-
2013
Price range of common stock — high	$	63.19	$	73.13		$	84.68	$	88.57
— low	$	53.91	$	61.88		$	71.12	$	72.64
Dividends declared per common share	$	0.04	$	-		$	-	$	-

(1)The first quarter of 2013 includes an after-tax gain of $25 millionfor the GMIB business, an after-tax charge of $507 million for the reinsurance transaction with Berkshire to effectively exit the Run-off Reinsurance business, and an after-tax charge of $51 million related to the disability claims regulatory matter in the Group Disability and Life segment.

(2)       The second quarter of 2013 includes an after-tax charge of $24 million for the Pharmacy Benefits Manager (“PBM”) partnering agreement with Catamaran.

(3)       The fourth quarter of 2013includes an after-taxcharge of $40 million foranorganizational efficiency plan.